Bookrunners Cowen, Piper Jaffray and Stifel to assist with financing
By Devika Patel
Knoxville, Tenn., July 30 – Genocea Biosciences Inc. said it priced a $50.05 million public offering of stock with a $7.51 million greenshoe. The offering was announced Wednesday.
The company will sell 3.85 million common shares at $13.00 per share. The price per share reflects a 6.54% discount to the July 29 closing share price of $13.91.
Cowen and Co., LLC, Piper Jaffray & Co. and Stifel, Nicolaus & Co., Inc. are the bookrunners.
Settlement is expected Aug. 4.
Proceeds will be used for clinical development of GEN-003 and GEN-004, new research programs and other general corporate purposes.
The biopharmaceutical company is based in Cambridge, Mass.
| Issuer: | Genocea Biosciences Inc.
|
| Issue: | Common stock
|
| Amount: | $50.05 million
|
| Greenshoe: | $7,507,500, or 577,500 shares
|
| Shares: | 3.85 million
|
| Price: | $13.00
|
| Warrants: | No
|
| Bookrunners: | Cowen and Co., LLC, Piper Jaffray & Co. and Stifel, Nicolaus & Co., Inc.
|
| Co-manager: | Needham & Co., LLC
|
| Announcement date: | July 29
|
| Pricing date: | July 30
|
| Settlement date: | Aug. 4
|
| Stock symbol: | Nasdaq: GNCA
|
| Stock price: | $13.91 at close July 29
|
| Market capitalization: | $314.43 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
